NYAM Names 2017 Lewis Rudin Glaucoma Prize Winner

 

New York Academy of Medicine pic

New York Academy of Medicine
Image: nyam.org

Mitchell Blutt, MD, is a pioneer in the private healthcare sector, the first doctor to successfully transition from practicing clinical medicine to a role as a professional healthcare investor. Now serving as CEO of Consonance Capital in New York City, Mitchell Blutt, MD is involved in a number of health-related organizations, including the New York Academy of Medicine.

For 22 years, the New York Academy of Medicine has awarded the Rudin Glaucoma Prize to physicians and researchers who demonstrate excellence in studying glaucoma as evidenced by their high-level contributions to peer-reviewed scientific journals. For the 2017 calendar year, the academy chose Mary Kelly, PhD, of Oregon Health & Science University as its winner, recognizing her paper titled, “Induced Pluripotent Stem Cells Restore Function in a Human Cell Loss Model of Open-Angle Glaucoma.”

The groundbreaking research discussed in this article is the first to show that stem cells can be used to deal with the baseline biological causes of glaucoma. Standard treatment manages the symptoms, but the use of stem cells could potentially give doctors a way to reverse the condition instead.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s